Canada Contrast Media Injectors Market Size and Competitive Analysis by 2027

The Canada contrast media injectors market is expected to reach US$ 99.0 Mn in 2027 from US$ 54.4 Mn in 2018. The market is estimated to grow with a CAGR of 7.0% from 2019-2027.

The growth of the market is driven by the factors such as development in diagnostic imaging modalities and rising geriatric population coupled with increasing number of chronic diseases. However, the market is likely to get affected during the forecast period due to shortage of skilled professionals.

In 2015, the Canadian Agency for Drugs and Technologies in Health, following the Canadian Institute for Health Information’s (CIHI’s) data collection until 2012 collected information on 6 modalities using a Web-based survey and summarized the results of the second iteration of the CADTH Canadian Medical Imaging Inventory. The data led to subsequent findings in the trend of medical imaging tests performed in Canada. In 2017, a total of 5.61 million CT examinations were performed in the most recent fiscal year in Canada, up from 3.38 million in 2007. Moreover, the data also suggests that 1.86 million MRI examinations were performed in 2017 among 561 diagnostic centers in Canada, while PET-CT accounted for a total of 90,530 examinations in the year of 2017.

Additionally, the emergence of local players in the market is expected to offer significant growth opportunities during the coming years. The majority of medical devices used in the Canadian healthcare system are imported. However, medical device exports are witnessed on the rise in the recent years. Canada is home to a robust manufacturing industry with hubs in Ontario and Quebec. Diagnostic equipment is in greatest demand, as well as patient monitoring equipment, consumables, patient aids, orthopedics/prosthetics, and dental products. Since, the regulatory procedures are well-established in the country, manufacturers with FDA clearance in the US have an easier time transitioning into the Canadian market.

The Canada contrast media injectors market is segmented based on product and application. Among the product segment, the consumables segment is expected to grow at a significant rate of 7.4% during the forecast period. In addition, the segment is also anticipated to dominate the market by products during the year 2027, with a market share of around 64.8%

Canada Contrast Media Injectors Market Revenue and Forecasts to 2027 (US$ Mn)

 

CANADA CONTRAST MEDIA INJECTORS– MARKET SEGMENTATION

By Product

• Injector Systems

  • MRI Injector Systems
  • CT Injector Systems
  • Angiography Injector Systems
• Consumables
  • Injector Heads
    • Single Head Injectors
    • Dual Head Injectors
    • Syringe less Injectors
  • Tubing
  • Syringes
  • Other Consumables
• Accessories

 

CANADA CONTRAST MEDIA INJECTORS – MARKET SEGMENTATION

By Application

• Interventional Cardiology
• Interventional Radiology
• Radiology

Companies Mentioned

• Bayer AG
• Shenzhen Xinguan Electromechanical Co. Ltd.
• Nemoto Kyorindo Co., Ltd.
• APOLLO RT Co. Ltd.
• General Electric
• AngioDynamics
• ulrich GmbH & Co.KG
• Bracco Imaging S.p.A.
• Guerbet SA
• Sino Medical-Device Technology Co., Ltd.
• Smiths Medical
• Medical Systems

Canada Contrast Media Injectors Report Scope